BTG plc (LON:BTG – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 840 ($11.24) and traded as high as GBX 840 ($11.24). BTG shares last traded at GBX 840 ($11.24), with a volume of 271,742 shares changing hands.
BTG Price Performance
The company has a market capitalization of £3.26 billion and a PE ratio of 29.47. The stock’s 50 day simple moving average is GBX 840 and its 200-day simple moving average is GBX 840.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Recommended Stories
- Five stocks we like better than BTG
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Top Stocks Investing in 5G Technology
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Why Invest in 5G? How to Invest in 5G Stocks
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.